D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
45,500
-2,650 (-5.50%)
Apr 2, 2025, 3:30 PM KST

D&D Pharmatech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
480,847513,608----
Upgrade
Enterprise Value
460,073494,061----
Upgrade
Last Close Price
45500.0048600.00----
Upgrade
PS Ratio
40.3444.91----
Upgrade
PB Ratio
6.867.38----
Upgrade
P/TBV Ratio
14.4514.45----
Upgrade
EV/Sales Ratio
40.2343.20----
Upgrade
Debt / Equity Ratio
0.140.140.151.470.320.03
Upgrade
Asset Turnover
0.130.130.220.000.01-
Upgrade
Quick Ratio
3.203.202.280.471.146.63
Upgrade
Current Ratio
3.583.582.610.611.227.28
Upgrade
Return on Equity (ROE)
-47.25%-47.25%9.29%-174.72%-43.71%-38.23%
Upgrade
Return on Assets (ROA)
-17.70%-17.70%-9.75%-24.89%-19.70%-16.52%
Upgrade
Return on Capital (ROIC)
-21.91%-21.91%-15.45%-37.70%-25.64%-25.07%
Upgrade
Earnings Yield
-5.95%-5.57%----
Upgrade
FCF Yield
-4.62%-4.32%----
Upgrade
Buyback Yield / Dilution
-13.66%-13.66%-10.67%2.05%-12.66%-118.38%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.